Smith & Nephew PLC (LSE:SN) — Market Cap & Net Worth

$105.79 Million USD  · GBX869.47 Billion GBX  · Rank #19067

Market Cap & Net Worth: Smith & Nephew PLC (SN)

Smith & Nephew PLC (LSE:SN) has a market capitalization of $105.79 Million (GBX869.47 Billion) as of September 17, 2026. Listed on the LSE stock exchange, this UK-based company holds position #19067 globally and #108 in its home market, demonstrating a -2.49% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Smith & Nephew PLC's stock price GBX1037.50 by its total outstanding shares 838040613 (838.04 Million). Also see balance sheet size of Smith & Nephew PLC for a full breakdown of the balance sheet.

Smith & Nephew PLC Market Cap History: 2015 to 2026

Smith & Nephew PLC's market capitalization history from 2015 to 2026. Data shows growth from $96.16 Million to $105.79 Million (1.33% CAGR). Also see how efficiently does Smith & Nephew PLC generate cash for how efficiently the company converts equity into cash flow.

Index Memberships

Smith & Nephew PLC is a constituent of 6 market indices:

Index Total Market Cap Weight (%) Rank by Market Cap
FTSE All-Share
FTAS
$64.22 Billion 0.16% #61 of 573
FTSE 350
FTLC
$64.15 Billion 0.16% #60 of 350
FTSE 100 Index (UK)
FTSE
$54.45 Billion 0.19% #54 of 100
STOXX Europe Large 200 EUR Price
LCXP
$7.27 Trillion 0.00% #149 of 182
STOXX Europe Large 200 Net Return
LCXR
$7.27 Trillion 0.00% #149 of 182
FTSE 350 Health Care Equipment & Services
NMX4530
$169.56 Million 62.39% #1 of 3

Weight: Smith & Nephew PLC's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Smith & Nephew PLC Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Smith & Nephew PLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Smith & Nephew PLC (SN) stock price for real-time trading data and today's change.

Latest Price to Sales (P/S) Ratio

0.02x

Smith & Nephew PLC's market cap is 0.02 times its annual revenue

Industry average: 2.29x Lower than industry average

Latest Price to Earnings (P/E) Ratio

0.20x

Smith & Nephew PLC's market cap is 0.20 times its annual earnings

Industry average: 18.23x Lower than industry average

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
2016 $99.08 Million $4.67 Billion $784.00 Million 0.02x 0.13x
2017 $106.69 Million $4.76 Billion $767.00 Million 0.02x 0.14x
2018 $124.67 Million $4.90 Billion $663.00 Million 0.03x 0.19x
2019 $159.57 Million $5.14 Billion $600.00 Million 0.03x 0.27x
2020 $134.98 Million $4.56 Billion $448.00 Million 0.03x 0.30x
2021 $118.90 Million $5.21 Billion $524.00 Million 0.02x 0.23x
2022 $105.41 Million $5.21 Billion $223.00 Million 0.02x 0.47x
2023 $106.19 Million $5.55 Billion $263.00 Million 0.02x 0.40x
2024 $101.09 Million $5.81 Billion $412.00 Million 0.02x 0.25x
2025 $126.28 Million $6.29 Billion $638.11 Million 0.02x 0.20x

Competitor Companies of SN by Market Capitalization

Companies near Smith & Nephew PLC in the global market cap rankings as of September 17, 2026. Review Smith & Nephew PLC tangible equity quality to assess the quality of the company's equity after excluding intangible assets.

Key companies related to Smith & Nephew PLC by market ranking:

  • Abbott Laboratories (NYSE:ABT): Ranked #125 globally with a market cap of $177.42 Billion USD.
  • Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
  • Stryker Corporation (NYSE:SYK): Ranked #232 globally with a market cap of $107.98 Billion USD.
  • Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#125 Abbott Laboratories NYSE:ABT $177.42 Billion $102.03
#229 Medtronic PLC NYSE:MDT $109.30 Billion $93.75
#232 Stryker Corporation NYSE:SYK $107.98 Billion $281.50
#239 Medtronic plc SA:MDTC34 $104.84 Billion R$208.39

Smith & Nephew PLC Historical Marketcap From 2015 to 2026

Between 2015 and today, Smith & Nephew PLC's market cap moved from $96.16 Million to $ 105.79 Million, with a yearly change of 1.33%.

Year Market Cap Change (%)
2026 GBX105.79 Million -16.23%
2025 GBX126.28 Million +24.92%
2024 GBX101.09 Million -4.80%
2023 GBX106.19 Million +0.74%
2022 GBX105.41 Million -11.35%
2021 GBX118.90 Million -11.91%
2020 GBX134.98 Million -15.41%
2019 GBX159.57 Million +28.00%
2018 GBX124.67 Million +16.84%
2017 GBX106.69 Million +7.69%
2016 GBX99.08 Million +3.03%
2015 GBX96.16 Million --

End of Day Market Cap According to Different Sources

On Sep 16th, 2026 the market cap of Smith & Nephew PLC was reported to be:

Source Market Cap
Yahoo Finance $105.79 Million USD
MoneyControl $105.79 Million USD
MarketWatch $105.79 Million USD
marketcap.company $105.79 Million USD
Reuters $105.79 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Smith & Nephew PLC

LSE:SN UK Medical Devices
Market Cap
$105.79 Million
GBX869.47 Billion GBX
Market Cap Rank
#19067 Global
#108 in UK
Share Price
GBX1037.50
Change (1 day)
-1.05%
52-Week Range
GBX1008.50 - GBX1417.50
All Time High
GBX1690.00
About

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; t… Read more